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THE IMPACT OF BODY MASS INDEX ON PATIENT REPORTED OUTCOME 1 
MEASURES (PROMs) AND COMPLICATIONS FOLLOWING PRIMARY HIP 2 
REPLACEMENT 3 
 4 
 5 
Abstract 6 
 7 
The influence of BMI upon patient-reported outcomes (OHS/EQ-5D index) and complications 8 
following THR was examined for a cohort of patients using linked national data. Outcomes 9 
were compared across BMI groups (19.0kg/m
2
-29.9kg/m
2
 [Reference], 30.0kg/m
2
-34.9kg/m
2
 10 
[Obese class I], 35.0kg/m
2
+ [Obese class II/III]), adjusted for case-mix differences. Obese 11 
class I patients had a significantly smaller improvement in OHS (18.9 versus 20.5, p<0.001) 12 
and a greater risk of wound complications (odds ratio [OR]=1.57, p=0.006).  For obese 13 
class II/III patients, there were significantly smaller improvements in OHS (p<0.001) and 14 
EQ-5D index (p<0.001), and a greater risk of wound complications (p=0.006), readmission 15 
(p=0.001) and reoperation (p=0.003). Large improvements in OHS and EQ-5D index were 16 
seen irrespective of BMI, although improvements were marginally smaller and complication 17 
rates higher in obese patients. 18 
 2 
 
Introduction 19 
Body mass index (BMI) and rates of obesity within the population are increasing across the 20 
developed world (1), resulting in poorer general health and greater risk of lower limb 21 
osteoarthritis (OA) (2, 3).   The National Joint Registry (NJR) in England and Wales has 22 
noted a year-on-year increase in total hip replacements (THRs) performed overall and in 23 
obese patients, with 38% having a BMI over 30kg/m
2
 in 2011 compared with less than 30% 24 
in 2003 (4).   25 
 26 
There is some evidence that lower limb arthroplasty in obese patients is more technically 27 
demanding (due to instrumentation issues), takes longer to perform (5), is associated with 28 
higher surgical and medical complications in the early post-operative period (6, 7), and 29 
outcomes such as function and implant longevity may be poorer (8-10).  Thus, raised BMI 30 
might be used to ration primary THR in a public funded health service, in effect denying 31 
patients access to surgical intervention (11).  Restrictions might apply to BMIs >35kg/m
2
, 32 
although lower cut-off limits have been proposed (12).  However, the evidence for denying 33 
access to a hip surgeon for patients with a high BMI is limited, and may be inappropriate (13, 34 
14). 35 
 36 
Patient reported outcome measures (PROMs) offer patient-centred evidence of the benefit of 37 
a procedure, and supplement clinical measures traditionally used to assess the success of joint 38 
replacement such as risk of revision (15). PROMs have been routinely collected by the 39 
Department of Health (DoH) for National Health Service (NHS) patients undergoing THR in 40 
England and Wales since 2008.  PROMs include a joint specific score, a general health 41 
measure and self-reported complication data.  These can now be linked to the NJR dataset in 42 
order to compare early outcomes for specific patient and implant groups at a national level.  43 
 3 
 
This analysis explores the impact of BMI on PROMs and complications following primary 44 
THR.   45 
 4 
 
Methods 46 
Design 47 
A retrospective cohort study was conducted using prospectively collected patient-level NJR 48 
and PROMs-linked data to compare general and joint specific outcome scores and self-49 
reported complications at a minimum 6 months following primary THR in patients with 50 
varying BMI.   51 
 52 
Data 53 
Data on hip replacement patients, their surgeons and implants used are collected by the NJR 54 
across England and Wales.  The national PROMs study collects joint-specific and general 55 
health scores pre- and six months post-operatively.  Self-reported post-operative 56 
complications are also available. By linking the two datasets at the level of the patient we 57 
were able to combine PROMs with the corresponding demographic and operative details held 58 
in the NJR.  In order to link the two datasets a number of linkage criteria were used.  Firstly, 59 
to ensure correct matching, two unique identifiers (NJR and procedure numbers) recorded in 60 
both datasets were used. Secondly, the operation date recorded by the patient in the PROMs 61 
data had to be within +/-30 days of the operation date recorded on the NJR record, to ensure 62 
the patient was scoring the same procedure.     63 
 64 
We chose to perform the analysis using the single most commonly used brand of cemented 65 
and cementless THR, in order to control for any implant influences while providing widely 66 
applicable results for THRs performed in England and Wales.  According to the NJR 8
th
 67 
Annual Report, the commonest cemented THR brand used since 2003 is the Exeter V40 hip 68 
and Contemporary socket (Stryker Orthopaedics, Mahwah, New Jersey, United States), 69 
accounting for 23.2% of all cemented THRs (37,995 of 163,981) (16). The Corail 70 
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stem/Pinnacle cup (DePuy Ltd, Leeds, United Kingdom) is the most commonly used 71 
cementless THR (31.2% [40,879] of 130,920 cementless THRs).  72 
 73 
There were a number of exclusion criteria.  For the NJR data these were: all procedures with 74 
an indication other than OA, procedures with missing implant or patient data, and procedures 75 
with missing or outlying BMI (<19kg/m
2
 or >65kg/m
2
) data were excluded.  Procedures with 76 
PROMs data that were missing, undated, dated more than 12 months prior to or following the 77 
operation, or non-identical duplicates were excluded; for identical duplicates the first record 78 
was retained for analysis.  Where the presence of a co-morbidity or complication was sought 79 
in the questionnaire but left blank by the patient, it was assumed to be absent.  The study 80 
population is summarised in Figure 1. The demographic, surgical and implant-related 81 
variables available for analysis are listed in Table 1.   82 
 83 
The national PROMs project uses validated measures of hip-specific (Oxford hip score 84 
[OHS]) (17) and general health outcomes (EuroQol [EQ-5D-3L]) (18). For this analysis the 85 
outcomes of interest were improvements between the pre- and post-operative scores (the 86 
‘change scores’) and self-reported post-operative complications (bleeding, wound problems, 87 
readmission and reoperation).  Change scores, being approximately normally distributed, are 88 
analytically preferable to post-operative scores (19).  The OHS (scored 0 lowest to 48 89 
highest) has previously been shown to be a reliable, valid and responsive outcome measure 90 
and can be used for the clinical assessment of large hip arthroplasty databases in a cross-91 
sectional population (20).  The EQ-5D-3L consists of 2 parts - the EQ-5D descriptive system 92 
and the EQ visual analogue scale (EQ VAS). The EQ-5D descriptive system evaluates five 93 
different aspects of general health (mobility, self-care, usual activities, pain/ discomfort and 94 
anxiety/depression). Each dimension has 3 levels: no problems, some problems, extreme 95 
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problems.  The respondent indicates his/her health state by ticking (or placing a cross) in the 96 
box against the most appropriate statement in each of the 5 dimensions.  These scores are 97 
then combined using population weightings to produce a single index value (-0.59 to 1.00) 98 
for health status (18). The EQ VAS records the respondent’s self-rated health on a visual 99 
analogue scale where the endpoints are ‘best imaginable health state’ and ‘worst imaginable 100 
health state’. This information can be used as a quantitative measure of health outcome; 101 
variations over time can be used for clinical and economic appraisal.  The EQ-5D-3L is 102 
commonly used throughout Europe for assessment in a variety of different clinical settings, 103 
including joint replacement, and was chosen by the Department of Health in the United 104 
Kingdom as the most suitable generic health measure for the PROMs project because reliable 105 
UK population weighting values were available (21) (For more information on EuroQol 106 
assessment visit http://www.euroqol.org).  Patients are also asked about comorbidities, 107 
general health and self-reported disability as part of the pre-operative PROMs questionnaire. 108 
These can be used to understand and match the differences in health status between patient 109 
groups.  Sample sizes for all the BMI groups were in excess of the minimum numbers 110 
identified in the PROMs feasibility pilot to identify meaningful differences (more than 111 
150/group) (19). 112 
 113 
Statistical analysis 114 
The variables available for the analyses are shown in Appendix Table 1.  To align with its 115 
clinical application, BMI was grouped into three categories: 19.0kg/m
2
-29.9kg/m
2
 (normal 116 
and overweight - reference group), 30.0kg/m
2
-34.9kg/m
2
 (Obese class I), 35.0kg/m
2
+ (Obese 117 
class II and III). BMI was also assessed as a continuous variable to ensure BMI categorisation 118 
did not qualitatively alter the findings. Differences in baseline characteristics across the BMI 119 
groups were analysed using analysis of variance test (ANOVA, continuous data variables) or 120 
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Chi-square test (categorical data variables).  Analyses of cemented and cementless 121 
procedures were performed independently as no attempt was made to adjust for baseline 122 
differences between types of implants. 123 
 124 
Univariable analysis was performed initially to identify variables potentially influencing each 125 
outcome, based on statistical rejection criteria of p>0.10; these variables were then included 126 
in the multi-variable models.  Analysis of covariance (ANCOVA) was used for testing 127 
differences in OHS and EQ5D index change scores across BMI groups. Multi-variable 128 
logistic regression was used to analyse differences in the risk of each of the complications 129 
across BMI groups.  Time from implantation to questionnaire completion was included in 130 
models to evaluate whether differences in duration of follow-up influenced findings.  Pre-131 
operative scores were included within all models, as recommended by the Oxford group (20).  132 
 133 
Reflecting analysis of a large dataset, statistical models for the change scores were evaluated 134 
with the margins function in STATA in order to provide predicted values (including 99% 135 
confidence intervals) for each of the BMI categories.  P-values are provided as statistical tests 136 
of the differences between the reference and other BMI categories.  For complication risks, 137 
results are presented as odds ratios (ORs) with 99% CIs: ratios greater than one indicate that 138 
risk is higher when compared with the reference BMI category. Due to the statistical methods 139 
employed, and the large population size, only covariates fitting models with p<0.01 were 140 
considered significant influences, to reduce the risk of Type 1 error.  All models were fitted 141 
using STATA 12 (StataCorp LP, Texas, USA).  142 
 143 
In order to provide ‘real-world’ clinical scenarios, predicted changes in OHS were produced 144 
for the cemented model using the margins function in STATA. This demonstrated the 145 
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differences in hip specific improvement when sex, differences in pre-existing health status 146 
and disability, and level of pre-operative OHS were specified within the model, in addition to 147 
BMI.  148 
 9 
 
Results 149 
There were 8547 NJR-PROMs linked primary procedures, of which 65% had BMI data. Of 150 
the remaining 5535, 2656 were cemented Exeter Contemporary and 2879 were cementless 151 
Corail Pinnacle. 152 
 153 
Cemented hip replacement baseline characteristics 154 
There were 1640 patients (61.7%) with a BMI of 19 to 29.9kg/m
2
, 695 (26.2%) 30 to 155 
34.9kg/m
2
 and 321 (12.1%) 35kg/m
2
 and over (Table 1).  Obese patients were more likely to 156 
be younger (p<0.001), female (p=0.002) and have a higher ASA grade (p<0.001).  Similarly, 157 
diabetes (p<0.001) and hypertension (p<0.001) were more prevalent in patients with higher 158 
BMI, but proportions of other comorbidities were not significantly different.  Pre-operative 159 
general health (p<0.001) was poorer and self-reported disability (p<0.001) more common in 160 
obese patients.   161 
 162 
Pre-operative scores were significantly lower in obese patients (OHS: p<0.001, EuroQol 163 
VAS: p<0.001, EQ5D index: p<0.001); time from operation to post-operative questionnaire 164 
completion was similar across groups (209.0 to 209.6 days, p=0.636) (Table 1).   165 
 166 
Cementless hip replacement baseline characteristics 167 
There were 1738 patients (60.4%) with a BMI of 19 to 29.9kg/m
2
, 713 (24.8%) 30 to 168 
34.9kg/m
2
 and 428 (14.9%) 35kg/m
2
 and over (Table 2).  Similarly to the cemented group, 169 
obese patients were more likely to be younger (p<0.001) and have a higher ASA grade 170 
(p<0.001), but there were no differences in proportions of females.  Diabetes (p<0.001), 171 
hypertension (p<0.001) and depression (p=0.006) were more prevalent in patients with higher 172 
BMI, but proportions of other comorbidities were not significantly different.  Pre-operative 173 
 10 
 
general health (p<0.001) was poorer and self-reported disability (p<0.001) more common in 174 
obese patients.   175 
 176 
Pre-operative scores were significantly lower in obese patients (OHS: p<0.001, EuroQol 177 
VAS: p<0.001, EQ5D index: p<0.001); time from operation to post-operative questionnaire 178 
completion was similar across groups (207.6 to 210.0 days, p=0.985) (Table 2).   179 
 180 
Surgical factors 181 
The majority of operations were performed through the posterior approach (cemented: 55.4% 182 
[1471]; cementless: 63.6% [1830]), with the patient in a lateral position (79.1% [2102]; 183 
78.4% [2256]), by a consultant (64.0% [1700]; 77.0% [2216]), and using regional anaesthesia 184 
(78.8% [1792]; 80.4% [1923]).  Low molecular weight Heparin (53.6% [1218]; 66.2% 185 
[1593]) and mechanical methods (80.3% [2133]; 89.9% [2636]) were used as venous 186 
thromboembolic prophylaxis in the majority of cases (Table 3). 187 
 188 
Oxford Hip Score improvement 189 
For the cemented procedure, univariable analysis showed no differences in OHS 190 
improvement across the BMI groups.  However, after adjusting for other influential variables, 191 
when compared with the reference BMI group (20.5, 99% CI 20.0 to 21.1), both obese class I 192 
(18.9, 99% CI 18.1 to 19.8, p<0.001) and class II/III patients (18.7, 99% CI 17.5 to 19.9, 193 
p<0.001) had a significantly lower improvement in OHS (Table 4).    194 
 195 
For cementless procedure, there was no difference in OHS improvement between BMI 196 
groups in univariable analysis. After risk adjusting, when compared with the reference BMI 197 
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group (21.5, 99% CI 21.1 to 22.1), obese class II/III patients (20.0, 99% CI 18.9 to 21.0, 198 
p<0.001) had a significantly lower improvement in OHS (Table 5).    199 
 200 
In the ‘real-world’ scenarios, when a male patient with a BMI between 19 and 29.9kg/m2 201 
reporting a pre-operative OHS of 10, no disability, very good preoperative health and 202 
minimal comorbidities undergoes a cemented THR, they should expect an improvement in 203 
OHS of 32.  A female patient with a BMI of 35kg/m
2
+, self-reported fair health, presence of 204 
disability and co-morbidities and a pre-operative OHS of 25, an improvement in OHS of only 205 
9 was predicted.  Self reported disability, pre-operative function and health scores, and 206 
comorbidities were greater influences on OHS change than BMI.  A lower pre-operative OHS 207 
predicts a greater improvement, whilst presence of a disability and comorbidities, poorer 208 
health and higher BMI predicts lower improvements in OHS (Table 6). 209 
  210 
EQ5D index improvement 211 
For the cemented procedure, there were no differences in EQ5D index improvement between 212 
BMI groups in univariable analysis.  After risk adjusting, both obese class I (0.394, 99% CI 213 
0.372 to 0.416, p=0.036) and class II/III patients (0.387, 99% CI 0.353 to 0.420, p=0.043) 214 
had lower improvement in EQ5D index when compared with the reference BMI group 215 
(0.416, 99% CI 0.401 to 0.431), but neither was significant at the threshold value (Table 4).    216 
 217 
For the cementless procedure and univariable analysis, the EQ5D index improvement was 218 
actually higher in obese class II/III patients (0.453, 99% CI 0.410 to 0.497, p=0.016) when 219 
compared with the reference group (0.408, 99% CI 0.386 to 0.429), but this failed to reach 220 
the significance threshold specified.  However, after risk adjustment obese class II/III patients 221 
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(0.371, 99% CI 0.341 to 0.401, p<0.001) had a significantly lower improvement in EQ5D 222 
index compared with the reference BMI group (0.425, 99% CI 0.410 to 0.441) (Table 5).    223 
 224 
Risk of complications 225 
In the cemented group there was a significantly increased risk of complications in obese class 226 
II/III patients compared to the reference group, adjusted for other variables: wound 227 
complications, OR=2.06, 99% CI 1.25 to 3.40, p<0.001; readmission, OR=1.99, 99% CI 1.17 228 
to 3.39, p=0.001; and, reoperation, (OR=2.73, 99% CI 1.14 to 6.53, p=0.003).  Complications 229 
were less pronounced in obese class I patients with only wound complications being 230 
significant at the 1% level (p<0.01), OR=1.57, 99% CI 1.03 to 2.38, p=0.006.  Bleeding risk 231 
was similar across all groups (Table 7).  232 
 233 
For the cementless group, wound complications were significantly higher in obese class II/III 234 
patients (OR=2.39, 99% CI 1.52 to 3.75, p<0.001) when compared to the reference group, 235 
after risk adjusting.  Complication risk between the reference and other BMI groups for 236 
bleeding, readmission and reoperation were similar (Table 8). 237 
 238 
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Discussion 239 
This retrospective cohort study using NJR-PROMs linked data provides evidence of large 240 
improvements in OHS and EQ5D index at 6 months following surgery irrespective of BMI, 241 
although improvements were marginally smaller and complication rates higher in obese 242 
patients, after adjusting for other influences.  Our key finding was that joint specific and 243 
general health gains were lower and the complication risks higher as BMI increased from 244 
obesity class I to II/III. These findings were similar for both cemented and cementless 245 
implants.  We also found that a number of other variables influence outcome scores in 246 
addition to BMI including self reported disability, pre-operative function and health scores, 247 
and comorbidities.  This finding is clinically important as it can be used to describe the 248 
potential benefit in function, together with the risks of complications, to individual patients.  249 
It also provides evidence that BMI in isolation should not be the sole determinant of 250 
restrictions in referral to orthopaedic services.   251 
 252 
Whilst this is the largest study to date to report the affect of BMI on functional outcome 253 
within single THR brands, there are some potential limitations for the findings. The study 254 
design is observational and thus vulnerable to omitted variables, which may have confounded 255 
our findings. Some data were unavailable for analysis; for example, radiological data on cup 256 
positioning (which may be more difficult in patients with higher BMI). Moreover, there were 257 
large numbers of procedures that could not be analysed, either because of dataset linkage 258 
issues, missing NJR or PROMs data fields or absent BMI data (35% of the linked NJR-259 
PROMs data).  Despite these limitations, the data available for analysis were extensive and 260 
adjustments for differences in the baseline characteristics of BMI groups (where available) 261 
were performed.  In addition, similarities between the unadjusted and adjusted models, and 262 
robustness under different model fitting assumptions support the stability of estimates. 263 
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 264 
It could be argued that all THR brands should be examined to increase numbers for analysis 265 
and broaden the scope of findings of the study. By restricting the implants to only the most 266 
commonly used from each group we were able to remove difficulties adjusting for the 267 
performance of different brands, which may be used in far smaller numbers and propensity in 268 
different sub-groups of patients.  The two implants analysed represent 29% (100,803) of all 269 
cemented and cementless implants (344,185) used in England and Wales since 2003.  The 270 
remaining 71% are made up of 140 femoral stem brands and 117 acetabular components (4).  271 
Despite the exclusion of other brands, the study cohort provided adequate numbers of 272 
procedures for analysis according to recommendations for sample size arising from the 273 
PROMs feasibility study (19) and by the Oxford score design group (20). Additionally, our 274 
sensitivity analyses, based on commonly used component sets in each type of hip, provided 275 
similar results, suggesting our findings may generalize across different bearings, head sizes 276 
and fixation methods.   277 
 278 
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Pre-operative health scores were included in our multi-variable analyses; it might be argued 279 
that these should not be included since patients with higher BMI are likely to have poorer 280 
function, potentially creating a flaw in the study findings, as multi-variable testing adjusts for 281 
the effect of pre-operative function. However, demographic data supports this; whilst 282 
different BMI groups were not exactly matched in terms of pre-operative scores, the 283 
differences were clinically small.  Moreover, by providing predicted OHS improvements for 284 
different clinical situations, this study has confirmed that BMI is only one of several 285 
important variables influencing outcome, and its (independent) influence on change score is 286 
small.  Interestingly, the differences in OHS improvement across groups is less than the 287 
threshold of 3 points suggested by the OHS designers to demonstrate a clinical important 288 
difference (20). 289 
 290 
Previous work has demonstrated that risk of revision is significantly (1.5 times) higher in 291 
patients with a BMI >30kg/m
2
 following cementless hip replacement with a Corail/Pinnacle 292 
(10), although BMI was not found to influence implant survival in analyses of the cemented 293 
Exeter Contemporary (22). This could be a result of greater subsidence risk with cementless 294 
implants in patients with a higher BMI, or may be an erroneous finding, as previously 295 
published work has proposed that weight rather than BMI directly influences implant survival 296 
(23). 297 
 298 
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Other studies of suggest that arthroplasty patients with a high BMI may have more 299 
complications (7), including a greater risk of infection (24) and dislocation (9, 25), slower 300 
recovery (26), and poorer function (9) after THR.  However, several studies have found 301 
consistently good improvement irrespective of BMI with comparable satisfaction and implant 302 
survival (27-29).  A study of 3290 THR patients found that morbidly obese (BMI>40kg/m
2
) 303 
patients had a similar change in outcome scores postoperatively to those with lower BMIs.  304 
Although final outcome scores were found to be lower (as in this current study) and 305 
complications higher, the authors concluded that morbidly obese patients may have as much 306 
to gain from THR as patients with a lower BMI (13).  This view was supported by an analysis 307 
of 1421 THRs by Andrew et al, in which no difference in OHS was found at 5 years between 308 
BMI groups (14).  In addition, they found little difference in change of OHS between 3 309 
months and 5 years following replacement, suggesting that the results at 6 to 12 months post-310 
operatively in our current study are a reliable indication of longer-term outcome.  311 
Interestingly, a similar study on TKR patients (without separate brand analysis) found no 312 
difference in change scores across different BMIs in 13,673 procedures (30). 313 
 314 
In summary, patients experience a good improvement in outcome following THR irrespective 315 
of BMI. However, improvements were slightly smaller and complication rates higher in 316 
obese patients, after adjusting for other influences.  A number of other patient variables also 317 
influence outcome scores in addition to BMI.  In terms of improvement in health and 318 
function, a high BMI in isolation should not be a justifiable reason for denying surgery within 319 
a public funded health service.  This sub-group of patients should be counselled that 320 
improvement following hip replacement is likely to be less than that for an equivalent normal 321 
weight individual.  Strategies to lower BMI, such as pre-operative weight loss programmes 322 
(including bariatric intervention (31)), should be considered. 323 
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Table 1. Patient demographics and PROMs data for cemented Stryker Exeter V40 Contemporary hip replacement, by 
body mass index 
 All patients Body mass index Differences 
between 
BMI 
groups* 
 19 to 29.9kg/m
2
 
(Reference 
group) 
30 to 34.9kg/m
2
 
(Obese class I) 
35kg/m
2 
+ 
(Obese class 
II/III) 
Number (%) 2656 1640 (61.7) 695 (26.2) 321 (12.1)  
Patient factors      
Age, mean years 
   (standard deviation [sd], range) 
73.3  
(7.7, 36.7 to 
93.7) 
74.3  
(7.6, 36.7 to 
93.7) 
72.3  
(7.4, 45.1 to 
92.9) 
70.7  
(7.4, 46.4 to 
92.1) 
p<0.001 
 
Females 1687  (63.5) 1025  (62.5) 430  (61.9) 232  (72.3) p=0.002 
ASA      
1 274  (10.3) 195  (11.9) 67    (9.6) 12    (3.7) p<0.001 
2 1912  (72.0) 1186  (72.3) 500  (71.9) 226  (70.4) 
3+ 470  (17.7) 259  (15.8) 128  (18.4) 83  (25.9) 
Co-morbidities      
Heart disease 268  (10.1) 149    (9.1) 83  (11.9) 36  (11.2) p=0.086 
Stroke 32    (1.2) 16    (1.0) 12    (1.7) 4    (1.3) p=0.314 
Diabetes 270  (10.2) 120    (7.3) 102  (14.7) 48  (15.0) p<0.001 
Hypertension 1219  (45.9) 682  (41.6) 360  (51.8) 177  (55.1) p<0.001 
Circulation 220    (8.3) 117    (7.1) 68    (9.8) 35  (10.9) p=0.020 
Lung 187    (7.0) 119    (7.3) 40    (5.8) 28    (8.7) p=0.196 
Depression 132    (5.0) 71    (4.3) 41    (5.9) 20    (6.2) p=0.151 
Preoperative general health      
Excellent 94    (3.6) 65    (4.0) 23    (3.4) 6    (1.9) p<0.001 
Very good 767  (29.4) 517  (32.1) 184  (26.9) 66  (20.9) 
Good 1207  (46.3) 727  (45.2) 328  (47.9) 152  (48.1) 
Fair 470  (18.0) 259  (16.1) 126  (18.4) 85  (26.9) 
Poor 72    (2.8) 41    (2.6) 24    (3.5) 7    (2.2) 
Preoperative disability 1548  (58.3) 901  (58.9) 425  (66.4) 222  (75.3) p<0.001 
Patient reported outcome scores      
Oxford Hip scores      
     Pre-operative, mean 
        (sd, range) 
18.2 
(8.1, 0 to 48) 
19.2 
(8.1, 0 to 44) 
17.4 
(7.9, 0 to 48) 
15.3 
(7.4, 1 to 40) 
p<0.001 
     Post-operative, mean 
        (sd, range) 
38.3 
(8.9, 2 to 48) 
39.4 
(8.3, 6 to 48) 
36.8 
(9.4, 2 to 48) 
35.7 
(9.6, 4 to 48) 
p<0.001 
 
EQ5D visual analogue score      
     Pre-operative, mean 
        (sd, range) 
67.1 
(19.8, 0 to 100) 
68.3 
(19.2, 0 to 100) 
67.2 
(20.4, 0 to 100) 
60.8 
(20.7, 4 to 100) 
p<0.001 
     Post-operative, mean 
        (sd, range) 
75.2 
(17.8, 0 to 100) 
76.6 
(17.4, 0 to 100) 
74.0 
(18.1, 0 to 100) 
70.7 
(18.6, 0 to 100) 
p<0.001 
EQ5D index      
     Pre-operative, mean 
        (sd, range) 
0.368 
(0.313, -0.484 to 1) 
0.392 
(0.307, -0.429 to 1) 
0.345 
(0.322, -0.484 to 1) 
0.305 
(0.315, -0.349 to 
0.796) 
p<0.001 
     Post-operative, mean 
        (sd, range) 
0.779 
(0.225, -0.239 to 1) 
0.799 
(0.217, -0.239 to 1) 
0.756 
(0.232, -0.239 to 1) 
0.728 
(0.235, -0.074 to 1) 
p<0.001 
Time from operation to PROMs 
completion, mean days (sd, 
range) 
 
209.2 
(29.1, 183 to 358) 
 
209.1 
(29.0, 183 to 358) 
 
209.6 
(29.4, 183 to 358) 
 
209.0 
(29.3, 184 to 337) 
 
p=0.636 
ASA – American Society of Anaesthesiologists score, PROMs – Patient reported outcomes measures 
* - analysis of variance test (continuous data variables) or Chi squared (categorical data variables)  
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Table 2. Patient demographics and PROMs data for cementless DePuy Corail Pinnacle hip replacement, by body mass 
index 
 All patients Body mass index Differences 
between 
BMI 
groups* 
 19 to 29.9kg/m
2
 
(Reference 
group) 
30 to 34.9kg/m
2
 
(Obese class I) 
35kg/m
2 
+ 
(Obese class 
II/III) 
Number (%) 2879 1738 (60.4) 713 (24.8) 428 (14.9)  
Patient factors      
Age, mean years 
   (standard deviation [sd], range) 
65.8  
(9.5, 25.2 to 
94.0) 
66.7 
(9.6, 26.2 to 
94.0) 
65.3  
(9.2, 25.2 to 
90.2) 
62.9  
(9.1, 28.7 to 
88.2) 
p<0.001 
 
Females 1602  (55.6) 979  (56.3) 374  (52.5) 249  (58.2) p=0.112 
ASA      
1 554  (19.2) 417  (24.0) 106  (14.9) 31    (7.2) p<0.001 
2 2057  (71.5) 1202  (69.2) 541  (75.9) 226  (73.4) 
3+ 268  (9.3) 119  (6.9) 66    (9.3) 83  (19.4) 
Co-morbidities      
Heart disease 226   (7.8) 130    (7.5) 51    (7.2) 45  (10.5) p=0.082 
Stroke 35    (1.2) 22    (1.3) 8    (1.1) 5    (1.2) p=0.953 
Diabetes 219    (7.6) 81    (4.7) 76  (10.7) 62  (14.5) p<0.001 
Hypertension 1123  (39.0) 582  (33.5) 300  (42.1) 241  (56.3) p<0.001 
Circulation 136    (4.7) 74    (4.3) 34    (4.8) 28    (6.5) p=0.136 
Lung 158    (5.5) 88    (5.1) 36    (5.0) 34    (7.4) p=0.054 
Depression 172    (6.0) 96    (5.5) 36    (5.0) 40    (9.3) p=0.006 
Preoperative general health      
Excellent 150    (5.4) 110    (6.6) 26    (3.8) 14    (3.4) p<0.001 
Very good 870  (31.5) 582  (35.0) 206  (30.0) 82  (19.8) 
Good 1210  (43.8) 698  (42.0) 321  (46.7) 191  (46.1) 
Fair 473  (17.1) 241  (14.5) 121  (17.6) 111  (26.8) 
Poor 61    (2.2) 31    (1.9) 14    (2.0) 16    (3.7) 
Preoperative disability 1405  (53.9) 783  (50.1) 350  (53.9) 272  (68.9) p<0.001 
Patient reported outcome scores      
Oxford Hip scores      
     Pre-operative, mean 
        (sd, range) 
18.8 
(8.1, 1 to 43) 
19.9 
(8.1, 2 to 43) 
18.5 
(7.8, 2 to 43) 
15.1 
(7.3, 1 to 39) 
p<0.001 
     Post-operative, mean 
        (sd, range) 
40.1 
(8.6, 0 to 48) 
40.8 
(8.1, 6 to 48) 
40.0 
(8.3, 8 to 48) 
37.0 
(10.1, 1 to 48) 
p<0.001 
EQ5D visual analogue score      
     Pre-operative, mean 
        (sd, range) 
66.7 
(20.9, 0 to 100) 
68.5 
(20.1, 0 to 100) 
66.5 
(21.0, 0 to 100) 
60.1 
(22.7, 4 to 100) 
p<0.001 
     Post-operative, mean 
        (sd, range) 
77.1 
(18.4, 0 to 100) 
78.6 
(17.3, 0 to 100) 
77.3 
(17.3, 0 to 100) 
70.9 
(20.6, 0 to 100) 
p<0.001 
EQ5D index      
     Pre-operative, mean 
        (sd, range) 
0.381 
(0.313, -0.349 to 1) 
0.414 
(0.306, -0.349 to 1) 
0.379 
(0.310, -0.239 to 1) 
0.253 
(0.316, -0.349 to 
0.796) 
p<0.001 
     Post-operative, mean 
        (sd, range) 
0.799 
(0.246, -0.594 to 1) 
0.823 
(0.228, -0.594 to 1) 
0.800 
(0.231, -0.074 to 1) 
0.705 
(0.306, -0.319 to 1) 
p<0.001 
Time from operation to PROMs 
completion, mean days (sd, 
range) 
 
208.5 
(27.8, 183 to 363) 
 
208.5 
(27.8, 183 to 363) 
 
207.6 
(27.1, 183 to 363) 
 
2010.0 
(28.6, 183 to 362) 
 
p=0.985 
ASA – American Society of Anaesthesiologists score, PROMs – Patient reported outcomes measures 
* - analysis of variance test (continuous data variables) or Chi squared (categorical data variables) 
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Table 3. Surgical factors for populations studied 
 Cemented (Exeter 
Contemporary) 
Cementless  
(Corail Pinnacle) 
Number 2656 2879 
Approach   
Posterior 1471  (55.4) 1830  (63.6) 
Direct lateral 1117   (42.1) 888  (30.8) 
Other 68     (2.6) 161    (5.6) 
Chemical VTE prophylaxis   
LMWH only 1218   (53.6) 1593  (66.2) 
Aspirin only 233   (10.2) 208    (8.7) 
Other 701   (30.8) 379  (15.8) 
None 122     (5.4) 225    (9.4) 
Mechanical VTE prophylaxis   
GCS 747   (28.1) 912  (37.9) 
GCS/mechanical pump combination 663   (25.0) 662  (27.5) 
Foot pump only 413   (15.6) 221    (9.2) 
Mechanical calf pump only 280   (10.5) 350  (14.6) 
Other 30     (1.1) 17    (0.7) 
None 523   (19.7) 243  (10.1) 
Anaesthesia   
Regional 1085   (47.7) 1369  (57.2) 
General 481   (21.2) 470  (19.6) 
Regional and general 708   (31.1) 554  (23.2) 
Grade   
Consultant 1700  (64.0) 2216  (77.0) 
Other 956   (36.0) 663  (23.0) 
Position   
Lateral 2102   (79.1) 2256  (78.4) 
Supine 172     (6.5) 149    (5.2) 
Unknown 382   (14.4) 474  (16.5) 
VTE – Venous thromboemolism, LMWH – Low molecular weight Heparin, GCS – 
Graduated compression stockings  
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Table 4. Patient reported outcome scores following primary cemented Stryker Exeter V40 Contemporary hip 
replacement, by body mass index (simple and multivariable analyses) 
  Simple      Multivariable 
 Value 99% CI P value Value 99% CI P value 
Change in OHS       
BMI 19 to 29.9kg/m
2
 (n=1640) 20.2 19.5 to 20.8 Reference 20.5 20.0 to 21.1 Reference 
BMI 30 to 34.9kg/m
2
 (n=695) 19.5 18.5 to 20.4 0.116 18.9 18.1 to 19.8 <0.001 
BMI 35kg/m
2 
+ (n=321) 20.4 19.0 to 21.8 0.708 18.7 17.5 to 19.9 <0.001 
Change EQ5D index        
BMI 19 to 29.9kg/m
2
 (n=1640) 0.408 0.386 to 0.431  Reference 0.416 0.401 to 0.431 Reference 
BMI 30 to 34.9kg/m
2
 (n=695) 0.410 0.376 to 0.444 0.928 0.394 0.372 to 0.416 0.036 
BMI 35kg/m
2 
+ (n=321) 0.418 0.367 to 0.468 0.669 0.387 0.353 to 0.420 0.043 
OHS – Oxford Hip Score, BMI – Body mass index 
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Table 5. Patient reported outcome scores following primary cementless DePuy Corail Pinnacle hip replacement, by body 
mass index (simple and multivariable analyses) 
  Simple      Multivariable 
 Value 99% CI P value Value 99% CI P value 
Change in OHS       
BMI 19 to 29.9kg/m
2
 (n=1738) 20.9 20.3 to 21.5 Reference 21.5 21.1 to 22.1 Reference 
BMI 30 to 34.9kg/m
2
 (n=713) 21.5 20.5 to 22.4 0.188 21.3 20.5 to 22.1 0.532 
BMI 35kg/m
2 
+ (n=428) 21.9 20.7 to 23.1 0.065 20.0 18.9 to 21.0 <0.001 
Change EQ5D index       
BMI 19 to 29.9kg/m
2
 (n=1738) 0.408 0.386 to 0.429  Reference 0.425 0.410 to 0.441 Reference 
BMI 30 to 34.9kg/m
2
 (n=713) 0.420 0.386 to 0.454 0.422 0.419 0.395 to 0.442 0.527 
BMI 35kg/m
2 
+ (n=428) 0.453 0.410 to 0.497 0.016 0.371 0.341 to 0.401 <0.001 
OHS – Oxford Hip Score, BMI – Body mass index 
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Table 6. Predicted OHS improvement for specific self-reported patient factors, based on cemented hip 
replacement model 
 Preoperative very good health Preoperative fair health 
 No disability Disability No disability Disability 
 Minimal co-
morbidity* 
Co-morbidity 
present ϕ 
Minimal co-
morbidity 
Co-morbidity 
present 
Minimal co-
morbidity 
Co-morbidity 
present 
Minimal co-
morbidity 
Co-morbidity 
present 
Females         
BMI 19 to 29.9kg/m
2
         
Pre-op OHS 10 30.4 26.0 28.4 23.9 29.6 25.1 26.2 23.1 
Pre-op OHS 15 26.4 21.9 24.3 19.9 25.5 21.1 22.1 19.1 
Pre-op OHS 20 22.4 17.9 20.3 15.9 21.5 17.1 18.1 15.0 
Pre-op OHS 25 18.3 13.9 16.3 11.9 17.5 13.1 14.1 11.0 
BMI 30 to 34.9kg/m
2
         
Pre-op OHS 10 28.9 24.5 26.9 22.4 28.1 23.6 24.7 21.6 
Pre-op OHS 15 24.9 20.4 22.8 18.4 24.1 19.6 20.6 17.6 
Pre-op OHS 20 20.9 16.4 18.8 14.4 20.0 15.6 16.6 13.5 
Pre-op OHS 25 16.9 12.4 14.8 10.4 16.0 11.6 12.6 9.5 
BMI 35kg/m
2 
+         
Pre-op OHS 10 28.8 24.4 26.8 22.3 28.0 23.5 24.6 21.5 
Pre-op OHS 15 24.8 20.4 22.8 18.3 24.0 19.5 20.6 17.5 
Pre-op OHS 20 20.8 16.3 18.7 14.3 19.9 15.5 16.5 13.5 
Pre-op OHS 25 16.8 12.3 14.7 10.3 15.9 11.5 12.5 9.4 
Males         
BMI 19 to 29.9kg/m
2
         
Pre-op OHS 10 32.2 27.8 30.2 25.7 31.4 26.9 28.0 24.9 
Pre-op OHS 15 28.2 23.8 26.2 21.7 27.4 22.9 24.0 20.9 
Pre-op OHS 20 24.2 19.8 22.1 17.7 23.4 18.9 19.9 16.9 
Pre-op OHS 25 20.2 15.7 18.1 13.7 19.3 14.9 15.9 12.8 
BMI 30 to 34.9kg/m
2
         
Pre-op OHS 10 30.7 26.3 28.7 24.2 29.9 25.5 26.5 23.4 
Pre-op OHS 15 26.7 22.3 24.7 20.2 25.9 21.4 22.5 19.4 
Pre-op OHS 20 22.7 18.3 20.7 16.2 21.9 17.4 18.5 15.4 
Pre-op OHS 25 18.7 14.2 16.6 12.2 17.8 13.4 14.4 11.4 
BMI 35kg/m
2 
+         
Pre-op OHS 10 30.7 26.2 28.6 24.2 29.8 25.4 26.4 23.3 
Pre-op OHS 15 26.6 22.2 24.6 20.1 25.8 21.4 22.4 19.3 
Pre-op OHS 20 22.6 18.2 20.6 16.1 21.8 17.3 18.4 15.3 
Pre-op OHS 25 18.6 14.2 16.6 12.1 17.8 13.3 14.4 11.3 
* Minimal co-morbidity – ASA 2, no depression, no circulatory problems 
ϕ Co-morbidity present – ASA 3, depression, circulatory problems 
BMI – Body mass index, ASA – American Society of Anaesthesiologists, Regional anaesthesia and posterior 
approach used in model. 
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Table 7. Patient reported complications following primary cemented Stryker Exeter V40 Contemporary hip replacement, 
by body mass index (simple and multivariable analyses) 
 
% n 
 Simple      Multivariable 
 OR 99% CI P value OR 99% CI P value 
Bleeding complications          
BMI 19 to 29.9kg/m
2
 (n=1640) 3.7 (61) 1   1   
BMI 30 to 34.9kg/m
2
 (n=695) 5.3 (37) 1.46 0.84 to 2.52 0.079 1.47 0.83 to 2.60 0.083 
BMI 35kg/m
2 
+ (n=321) 4.4 (14) 1.18 0.54 to 2.58 0.584 1.16 0.52 to 2.57 0.633 
Wound complications          
BMI 19 to 29.9kg/m
2
 (n=1640) 7.2 (118) 1   1   
BMI 30 to 34.9kg/m
2
 (n=695) 10.8 (75) 1.56 1.04 to 2.33 0.004 1.57 1.03 to 2.38 0.006 
BMI 35kg/m
2 
+ (n=321) 15.0 (48) 2.27 1.41 to 3.64 <0.001 2.06 1.25 to 3.40 <0.001 
Readmission         
BMI 19 to 29.9kg/m
2
 (n=1640) 6.2  (102) 1    1   
BMI 30 to 34.9kg/m
2
 (n=695) 8.8  (61) 1.45 0.94 to 2.24 0.027 1.45 0.94 to 2.24 0.028 
BMI 35kg/m
2 
+ (n=321) 11.2 (36) 1.90 1.13 to 3.22 0.002 1.99 1.17 to 3.39 0.001 
Reoperation         
BMI 19 to 29.9kg/m
2
 (n=1640) 1.6 (26) 1   1   
BMI 30 to 34.9kg/m
2
 (n=695) 2.7 (19) 1.74 0.79 to 3.83 0.068 1.67 0.76 to 3.68 0.095 
BMI 35kg/m
2 
+ (n=321) 4.4 (14) 2.83 1.19 to 6.75 0.002 2.73 1.14 to 6.53 0.003 
OR – Odds ratio, BMI – Body mass index 
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Table 8. Patient reported complications following primary cementless DePuy Corail Pinnacle hip replacement, by body 
mass index (simple and multivariable analyses) 
 
% n 
 Simple      Multivariable 
 OR 99% CI P value OR 99% CI P value 
Bleeding complications          
BMI 19 to 29.9kg/m
2
 (n=1738) 5.1 (89) 1   1   
BMI 30 to 34.9kg/m
2
 (n=713) 6.3 (45) 1.25 0.77 to 2.03 0.240 1.10 0.64 to 1.90 0.647 
BMI 35kg/m
2 
+ (n=428) 5.8 (25) 1.15 0.63 to 2.10 0.550 1.15 0.59 to 2.25 0.595 
Wound complications          
BMI 19 to 29.9kg/m
2
 (n=1738) 6.6 (115) 1   1   
BMI 30 to 34.9kg/m
2
 (n=713) 9.5 (68) 1.49 0.99 to 2.25 0.013 1.43 0.93 to 2.21 0.032 
BMI 35kg/m
2 
+ (n=428) 14.5 (62) 2.39 1.55 to 3.68 <0.001 2.39 1.52 to 3.75 <0.001 
Readmission         
BMI 19 to 29.9kg/m
2
 (n=1738) 6.3 (110) 1   1   
BMI 30 to 34.9kg/m
2
 (n=713) 5.5 (39) 0.86 0.52 to 1.40 0.419 0.87 0.50 to 1.50 0.503 
BMI 35kg/m
2 
+ (n=428) 7.0 (30) 1.12 0.64 to 1.93 0.608 1.32 0.72 to 2.41 0.233 
Reoperation         
BMI 19 to 29.9kg/m
2
 (n=1738) 2.0 (35) 1   1   
BMI 30 to 34.9kg/m
2
 (n=713) 1.4 (10) 0.69 0.27 to 1.76 0.309 0.69 0.27 to 1.76 0.309 
BMI 35kg/m
2 
+ (n=428) 2.3 (10) 1.16 0.46 to 2.96 0.675 1.16 0.46 to 2.96 0.675 
OR – Odds ratio, BMI – Body mass index 
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Supplementary material 441 
 442 
The reliability of the multi-variable statistical models was explored in a number of ways: 443 
covariates found not to be statistically significant were excluded from the model, based on 444 
statistical entry (p<0.05) criteria; the same covariates were fitted forward and reverse 445 
stepwise manually to ensure findings were not qualitatively affected in the final model, with 446 
any inconsistency reported; the final models were re-evaluated as a directly entered model 447 
(non-stepwise), and were assessed by exploring 2-way interactions between covariates.    448 
 449 
The purpose of the analysis was hypothesis generating rather than hypothesis testing, 450 
consequently there is no adjustment for multiple testing and the choice of level of statistical 451 
significance is somewhat arbitrary.   452 
 453 
To test the models generated, a sensitivity analysis was performed using only the most 454 
commonly implanted component sets within the cemented (28mm flanged cup, representing 455 
70% of all Exeter V40-Contemporary THRs implanted in 2010) and cementless groups 456 
(36mm hard bearing, representing 51% of all Corail Pinnacle THRs implanted in 2010). 457 
 458 
Tests for interaction (multiplicative) between covariates were not statistically significant. 459 
Forward and reverse stepwise model construction and varying significance thresholds led to 460 
the same final models.  Sensitivity analysis of the commonest component sets within 461 
cemented and cementless groups showed similar results for OHS and EQ5D index change, 462 
indicating that the findings of the entire cohort are applicable to a range of component 463 
choices within brands (Appendix Tables 3 and 4).  Treating BMI as a continuous or 464 
categorical variable did not qualitatively affect the model. 465 
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Appendix Table 1. Summary of demographic and surgical variables available for analysis (those found to have a significant 
influence on specific statistical models and therefore included in final models are shown) 
 Source Description Included in 
final models* 
Patient factors    
Age (years) NJR/PROMs  7 
Sex NJR/PROMs  A,E,1,3 
American Society of 
Anaesthesiology grade 
NJR Grades 1 to 4 E 
Body mass index (BMI) 
(kg/m
2
) 
NJR Only BMI within 15 kg/m
2
 to 65 kg/m
2
 included All 
Comorbidities PROMs Recorded by patients as part of the pre-operative PROMs 
questionnaire. Ten co-morbidities: i) ischaemic heart disease, ii) 
respiratory disease, iii) diabetes, iv) hypertension, v) kidney 
disease, vi) liver disease, vii) circulatory problems, viii) cancer, ix) 
depression, x) stroke 
A (vii), B 
(vii,ix), C 
(vii,ix), D (vii, 
ix, x), E 
(vii,ix), F 
(i,vii,ix) G 
(vii,ix,x), H 
(vii, ix, x), 6 
(iii), 4(v) 
Pre-operative general health PROMs Indicates the patient’s perception of their own general health with 
five options: i) excellent, ii) very good, iii) good, iv) fair, v) poor 
A,B,C,D,E,F,
G,H 
Pre-operative disability PROMs Indicates whether the patient considers themselves to have a 
disability 
A,B,C,D,E,F,
G,H, 1 
Pre-operative Oxford Hip 
Score 
PROMs Derived from adding the points (0 to 4) together from the response 
to hip symptom-specific questions on a scale of 0 to 48 (0 worst, 
48 best) 
A,C,E,F,G 
Pre-operative EQ5D Visual 
Analogue Score 
PROMs Indicates how well the patient feels on the day of completing the 
questionnaire on a scale of 0-100 (0 worst, 100 best) 
2 
Pre-operative EQ5D index PROMs Single summary score derived from EQ5D profile (based on 
response to 5 questions) by applying a formula with appropriate 
operation specific weightings (0 to 1) 
B,D,F,H 
Surgical factors    
Lead surgeon grade NJR Consultant or other No 
Hospital funding NJR NHS or other  
Approach NJR Posterior or direct lateral A,B,C,D,E,F,
G,H, 1,5 
Patient position NJR Lateral or supine No 
Anaesthesia NJR i) Regional only, ii) general only, iii) general and regional E 
Chemical venous 
thromboembolism 
prophylaxis 
NJR Intended prophylaxis as recorded at time of operation: i) aspirin 
only, ii) LMWH only, iii) other, iv) none 
7 
Mechanical venous 
thromboembolism 
prophylaxis 
NJR Intended prophylaxis as recorded at time of operation: i) TEDS 
only, ii) combination TEDS/mechanical pump, iii) foot pump only, 
iv) intermittent calf pump only, v) other, and vi) none 
6 
Time from operation to post-
operative PROMs completion 
PROMs Calculated from the date of operation as recorded on the NJR 
database to the date of post-operative PROMs as recorded on the 
questionnaire 
No 
PROMS outcome scores for: 
commonest cemented implants: A. OHS change, B. EQ5D index change 
commonest cementless implants: C. OHS change, D. EQ5D index change 
all cemented implants: E. OHS change, F. EQ5D index change 
all cementless implants: G. OHS change, H. EQ5D index change 
PROMS patient reported complications for: 
cemented implants: 1. wound, 2. bleeding, 3. readmission, 4. further surgery 
cementless implants: 5. wound, 6. bleeding, 7. readmission, 8. further surgery  
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Appendix Table 2. Demographics for sensitivity analysis 
 Cemented (Exeter Contemporary 
28mm flanged polyethylene) 
Cementless (Corail Pinnacle 
36mm hard bearing) 
Number 1532 1191 
Patient factors 
Age, mean years 
    (standard deviation [sd], 
range) 
72.8 
(7.7, 36.7 to 92.9) 
63.0 
(9.7, 25.2 to 89.0) 
Females 1036  (67.6) 540   (45.3) 
ASA   
1 165   (10.8) 282   (23.7) 
2 1106  (72.2) 814   (68.4) 
3 252   (16.5) 94    (7.9) 
4/5 9  (0.6) 1  (0.1) 
Body mass index (kg/m
2
)   
 BMI 19 to 29.9 924   (60.3) 712   (59.8) 
 30 to 34.9 417   (27.2) 285   (23.9) 
 35+ 191    (12.5) 194    (16.3) 
Co-morbidities   
Heart disease 137  (8.9) 95    (8.0) 
Stroke 19    (1.2) 12    (1.0) 
Diabetes 164   (10.7) 78    (6.6) 
Hypertension 706   (46.1) 438   (36.8) 
Circulation 122  (8.0) 37    (4.0) 
Lung 112  (7.3) 69    (5.8) 
Liver 6  (0.4) 5  (0.4) 
Kidney 21   (1.4) 13    (1.1) 
Nervous 13   (0.9) 7  (0.6) 
Cancer 88   (5.7) 39    (3.3) 
Depression 76   (5.0) 82    (6.9) 
Preoperative general health   
Excellent 57   (3.8) 62    (5.3) 
Very good 467  (31.0) 375   (32.3) 
Good 686  (45.5) 477   (41.1) 
Fair 265  (17.6) 220   (19.0) 
Poor 34   (2.3) 27    (2.3) 
Preoperative disability 868  (56.7) 553   (46.4) 
Preoperative OHS, mean score 
     (sd, range) 
18.4 
(8.1, 0 to 44) 
19.2 
(8.1, 2 to 42) 
Pre-opEQ5D VAS, mean score 
     (sd, range) 
67.6 
(19.7, 0 to 100) 
66.2 
(20.6, 0 to 100) 
Pre-op EQ5D index, mean 
     (sd, range) 
0.374 
(0.311, -0.429 to 1) 
0.387 
(0.317, -0.349 to 1) 
Time from operation to PROMs 
completion, mean days 
     (sd, range) 
 
208.9 
(29.1, 183 to 358) 
 
209.6 
(29.0, 183 to 362) 
Surgical factors 
Provider   
NHS 1313  (85.7) 1029  (86.4) 
Other 3  (0.2) 4  (0.3) 
Unknown 216   (14.1) 162   (13.6) 
Approach   
Posterior 866   (56.5) 765   (64.2) 
Direct lateral 628   (40.1) 337   (28.3) 
Other 38    (2.5) 89    (7.5) 
Chemical VTE prophylaxis   
LMWH only 623   (47.3) 625   (60.5) 
Aspirin only 153   (11.6) 126   (12.2) 
Other 438   (33.3) 193   (18.7) 
None 102     (7.8) 89    (8.6) 
Mechanical VTE prophylaxis   
GCS 431   (28.1) 400   (38.7) 
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GCS/mechanical pump 
combination 
 
335   (21.9) 
 
342   (33.1) 
Foot pump only 253   (16.5) 64    (6.2) 
Mechanical calf pump only 204   (12.3) 133   (12.9) 
Other 23    (1.5) 12    (1.2) 
None 286   (18.7) 82    (7.9) 
Anaesthesia   
Regional 708   (53.8) 562   (54.5) 
General 238   (18.1) 229   (22.2) 
Regional and general 370   (28.1) 241   (23.4) 
Grade   
Consultant 943   (61.6) 920   (77.3) 
Other 589   (38.5) 271   (22.8) 
Position   
Lateral 1211  (79.0) 964   (80.9) 
Supine 105  (6.9) 69    (5.8) 
Unknown 216   (14.1) 158   (13.3) 
OHS – Oxford hip score, VAS – Visual analogue score, NHS – National Health Service, VTE – 
Venous thromboemolism, LMWH – Low molecular weight Heparin, GCS – Graduated 
compression stockings  
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Appendix Table 3. Patient reported outcome scores following primary cemented Stryker Exeter V40 Contemporary hip 
replacement, by body mass index (simple and multivariable analyses) 
  Simple      Multivariable 
 Value 99% CI P value Value 99% CI P value 
Change in OHS (commonest implant 
specification*)  
      
BMI 19 to 29.9kg/m
2
 (n=924) 20.4 19.5 to 21.2  Reference 20.7 19.9 to 21.4 Reference 
BMI 30 to 34.9kg/m
2
 (n=417) 19.8 18.5 to 21.1 0.331 19.2 18.2 to 20.3 0.005 
BMI 35kg/m
2 
+ (n=191) 20.0 18.1 to 21.9 0.643 18.6 17.0 to 20.1 0.002 
Change EQ5D index (*)       
BMI 19 to 29.9kg/m
2
 (n=924) 0.406 0.376 to 0.436  Reference 0.410 0.390 to 0.431 Reference 
BMI 30 to 34.9kg/m
2
 (n=417) 0.414 0.370 to 0.457 0.722 0.392 0.363 to 0.422 0.190 
BMI 35kg/m
2 
+ (n=191) 0.408 0.343 to 0.474 0.945 0.377 0.334 to 0.421 0.082 
*Commonest implant specification: Exeter V40 Contemporary flanged polyethylene cup (internal diameter 28mm) 
OHS – Oxford Hip Score, BMI – Body mass index 
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Appendix Table 4. Patient reported outcome scores following primary cementless DePuy Corail Pinnacle hip 
replacement, by body mass index (simple and multivariable analyses) 
  Simple      Multivariable 
 Value 99% CI P value Value 99% CI P value 
Change in OHS (commonest implant 
specification*) 
      
BMI 19 to 29.9kg/m
2
 (n=712) 21.2 20.3 to 22.2  Reference 21.7 20.9 to 22.6 Reference 
BMI 30 to 34.9kg/m
2
 (n=285) 20.7 19.2 to 22.3 0.481 21.0 19.7 to 22.3 0.218 
BMI 35kg/m
2
 + (n=194) 22.0 20.1 to 23.8 0.369 19.9 18.3 to 21.5 0.009 
Change EQ5D index (*)       
BMI 19 to 29.9kg/m
2
 (n=712) 0.413 0.379 to 0.448  Reference 0.440 0.416 to 0.465 Reference 
BMI 30 to 34.9kg/m
2
 (n=285) 0.404 0.350 to 0.459 0.722 0.406 0.367 to 0.445 0.059 
BMI 35kg/m
2
 + (n=194) 0.449 0.383 to 0.515 0.217 0.358 0.312 to 0.405 <0.001 
*Commonest implant specification: Corail Pinnacle ceramic-on-ceramic or metal-on-metal with 36mm head 
OHS – Oxford Hip Score, BMI – Body mass index 
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